We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Among patients hospitalized with atrial fibrillation who ...
In patients with atrial fibrillation with low thrombosis risk but high bleeding risk, both standard- and low-dose DOACs are equally effective and safe. Standard-dose direct oral anticoagulant therapy ...
Patients with atrial fibrillation (AF) who use a direct oral anticoagulant (DOAC) dose that’s inconsistent with US Food and Drug Administration labeling—a practice believed, in many cases, to be ...
Among patients hospitalized for atrial fibrillation (AF) or flutter, prescription of an off-label dose of a direct oral anticoagulant (DOAC) at discharge remains relatively common, according to data ...
(WASHINGTON, June 6, 2024) – Patients with atrial fibrillation (Afib) who took low doses of blood-thinning medications known as direct oral anticoagulants (DOACs) experienced more bleeding episodes ...
Intravenous thrombolysis (IVT) demonstrates comparable safety outcomes between patients with acute ischaemic stroke taking direct oral anticoagulants (DOACs) and those not on oral anticoagulants (OACs ...
MADRID -- Extended low-dose apixaban (Eliquis) after venous thromboembolism (VTE) provoked by events like trauma or surgery in patients with obesity or other enduring risk factors dramatically reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback